The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer.

Autor: Buijs SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: s.buijs@erasmusmc.nl., van Dorst DCH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Kruip MJHA; Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands., van den Akker RFP; Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands., Cheung KL; Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands., Porrazzo R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Versmissen J; Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Jan Danser AH; Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Versteeg HH; Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands., Bos MHA; Department of Internal Medicine, Division of Thrombosis and Hemostasis, Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jan; Vol. 170, pp. 115969. Date of Electronic Publication: 2023 Dec 02.

CBD-oil as a potential solution in case of severe tamoxifen-related side effects.

Autor: Buijs SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. s.buijs@erasmusmc.nl., Braal CL; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Buck SAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Maanen NF; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Meijden-Erkelens LM; Clinical Cannabis Care Pharmacy, Breukelen, the Netherlands., Kuijper-Tissot van Patot HA; Clinical Cannabis Care Pharmacy, Breukelen, the Netherlands., Hoop EO; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Saes L; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van den Boogerd SJ; Department of Medical Oncology, Alexander Monro Hospital, Bilthoven, The Netherlands., Struik LEM; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., van Rossum-Schornagel QC; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Publikováno v: NPJ breast cancer [NPJ Breast Cancer] 2023 Aug 05; Vol. 9 (1), pp. 63. Date of Electronic Publication: 2023 Aug 05.

Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale.

Autor: Agema BC; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands. Electronic address: b.agema@erasmusmc.nl., Buijs SM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands., Sassen SDT; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group; Rotterdam, the Netherlands., Mürdter TE; Margarete Fischer-Bosch-Institute of Clinical Pharmacology; Stuttgart, Germany; University of Tübingen; Tübingen, Germany., Schwab M; Margarete Fischer-Bosch-Institute of Clinical Pharmacology; Stuttgart, Germany; Dept. of Clinical Pharmacology, University Hospital Tübingen; Tübingen, Germany; iFIT Cluster of Excellence (EXC2180) 'Image Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Koch BCP; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group; Rotterdam, the Netherlands., Jager A; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands., van Schaik RHN; Dept. of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands., Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center; Rotterdam, the Netherlands; Dept. of Clinical Pharmacy, Erasmus University Medical Center; Rotterdam, the Netherlands.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Apr; Vol. 160, pp. 114369. Date of Electronic Publication: 2023 Feb 06.

Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial.

Autor: Braal CL; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO box 2040, 3015 CN, Rotterdam, The Netherlands. c.braal@erasmusmc.nl., Westenberg JD; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO box 2040, 3015 CN, Rotterdam, The Netherlands., Buijs SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO box 2040, 3015 CN, Rotterdam, The Netherlands., Abrams S; Data Science Institute, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, UHasselt, Hasselt, Belgium.; Global Health Institute, Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium., Mulder TAM; Department of Clinical Chemistry, Erasmus MC University Center, Rotterdam, The Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC University Center, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO box 2040, 3015 CN, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus MC University Center, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO box 2040, 3015 CN, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Dr. Molewaterplein 40, PO box 2040, 3015 CN, Rotterdam, The Netherlands.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Aug; Vol. 195 (1), pp. 65-74. Date of Electronic Publication: 2022 Jul 16.